ArcGen Bioscience: Funding, Investors & Team (Sep 2026)
ArcGen Bioscience is a biopharmaceutical development company
ArcGen Bioscience has raised $6.7M across 1 funding round on record, the most recent a Series A of $6.7M announced in Jul 2026.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
ArcGen Bioscience Company Profile and Key Stats
Latest funding round on record: Jul 2026.
ArcGen Bioscience Funding Rounds
ArcGen Bioscience Investors
11 investors are recorded in total; the 5 named above are those the record identifies.
ArcGen Bioscience Funding Compared to Other Biotechnology Startups
ArcGen Bioscience's latest round of $6.7M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like ArcGen Bioscience in Biotechnology and Daejeon
Companies Similar to ArcGen Bioscience
Lego Chem Bioscience , a company created by people with dreams and enthusiasm for global new drug…
April Bio is a drug development company that develops antibodies and long-acting biologics.
The company is a spin-off from Asan Medical Center, University of Ulsan University, with a primary objective…
LabGenomics is a healthcare company specialized in molecular diagnostics.
Galaxy operates a pharmaceutical research and development company for the treatment of encephalopathy and…
SPARK BioPharma Co., Ltd. was established in Seoul National University in January 2016 based on the unique…
3billion was founded with the goal of ending the diagnostic odyssey of rare disease patients through…
Shaperon is a clinical-stage biotech company that develops inflammasome inhibitors.
SN BioScience provide nano-formulation screening services for small molecule, oligonucleotide (siRNA, DNA),…
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
iPremom is a healthcare technology company that develops molecular diagnostic solutions for the early…
Wren Bioscience is developed to give rapid, reliable bacterial identification anywhere milk safety is…
ArcGen Bioscience Funding FAQs
What does ArcGen Bioscience do?
ArcGen Bioscience is a biopharmaceutical development company
How much funding has ArcGen Bioscience raised?
ArcGen Bioscience has raised $6.7M across 1 round on record. The most recent is a Series A of $6.7M announced in Jul 2026.
When did ArcGen Bioscience last raise funding?
ArcGen Bioscience's most recent funding round on record is a Series A of $6.7M, announced in Jul 2026.
Who has invested in ArcGen Bioscience?
Investors on record for ArcGen Bioscience include The Iron Partners, Korea Credit Guarantee Fund, IMM Investment, Huons, Yuanta Investment. FundedIQ records 11 investors in total.
Where is ArcGen Bioscience headquartered?
ArcGen Bioscience is based in Daejeon, South Korea.
When was ArcGen Bioscience founded?
ArcGen Bioscience was founded in 2021.
How does ArcGen Bioscience's funding compare to other Biotechnology startups?
ArcGen Bioscience's latest round of $6.7M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's ArcGen Bioscience Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for ArcGen Bioscience is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.